UDG-12668-71926
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 298 / SC
- Registered
- 2022-07-02
- Relationship
- Child or adolescent in my care
- Guardian
- DQL-84600-80447
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Dose 1 — Pfizer-BioNTech
-
2022-07-02
Registered in v-safe
- 2022-07-02
- 2022-07-06
- 2022-07-11
-
2022-07-29
Dose 2 — Pfizer-BioNTechCo-administered: MMR:Tetanus
- 2022-08-02
-
2022-08-04
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Office visit — Feeling: Fair · Sleepiness, Vomiting · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Primary CareMedDRA releases: 2024-11 · check-in free text available
-
2022-08-04
Report sent to call center — days 1–6 daily, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-08-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-12
- 2022-09-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-27 | Pfizer-BioNTech | No |
| 2 | 2022-07-29 | Pfizer-BioNTech | MMR:Tetanus |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Healthcare visit (other): Primary Care
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release